Pure Global

Multiple-type respiratory pathogen nucleic acid IVD, kit, nucleic acid technique (NAT) - UK MHRA Medical Device Registration

Multiple-type respiratory pathogen nucleic acid IVD, kit, nucleic acid technique (NAT) is a medical device registered with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) under Device ID 155957. The device is manufactured by BGI PathoGenesis Pharmaceutical Technology Co., Ltd. from China, classified as In Vitro Diagnostic Device. The authorized representative in the UK is SUNGO Certification Company Limited.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, device classification, authorized representative details, and related products. Pure Global AI offers free access to 150,962+ UK MHRA medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
MHRA Registered
In Vitro Diagnostic Device
๐Ÿ‡ฌ๐Ÿ‡ง
Multiple-type respiratory pathogen nucleic acid IVD, kit, nucleic acid technique (NAT)
MHRA Device ID: 155957โ€ขRef: 155957

Device Type

In Vitro Diagnostic Device

Devices

Multiple-type respiratory pathogen nucleic acid IVD, kit, nucleic acid technique (NAT)

Type

IVD General

Date Registered

Nov 26, 2024

Last Updated

Oct 8, 2023

Manufacturer Information

Address

0605A, Port Building, Shipping Center 59 Linhai Avenue, Nanshan Street Qianhai Shengang Cooperation Zone, Shenzhen

Guangdong Province, China

Created Date

Sep 9, 2022

Authorized Representative

Relationship Type

UK Responsible Person

Address

3rd Floor, 70 Gracechurch Street

London, England, United Kingdom

Postcode: EC3V 0HR

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Other Products from Same Authorized Representative (10)